このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Virtual Reality-Assisted Nursing Intervention During Intrauterine Device Insertion (VR-IUD)

2026年10月30日 更新者:YASEMİN ATEŞEYAN、Mersin University

Effect of Virtual Reality-Assisted Nursing Intervention on Pain and Anxiety During Intrauterine Device Insertion: A Randomized Controlled Trial

This randomized controlled trial evaluated the effects of a virtual reality-supported nursing intervention based on Kolcaba's Comfort Theory on women's comfort, emotional state, pain and physiological parameters during intrauterine device insertion. Seventy women attending a family planning clinic were individually randomized by lottery to a virtual reality group, who received the intervention in addition to routine care, or to a control group, who received routine care only.

調査の概要

状態

完了

条件

介入・治療

詳細な説明

Study hypotheses

Compared with the control group (routine care without virtual reality), women receiving the virtual reality-assisted nursing intervention (experimental group):

  • experience a lower level of pain during the procedure;
  • experience lower levels of anxiety during the procedure;
  • exhibit a lower stress response in physiological parameters (pulse rate, blood pressure and respiratory rate);
  • experience higher levels of comfort during the procedure. Condition: Pain, anxiety, physiological parameters and comfort of women during intrauterine device (IUD) insertion Intervention: Virtual reality-assisted nursing intervention Population: Women who have decided to have an IUD inserted Note on outcomes: In the initial registration, pain was erroneously listed as the primary outcome. The primary outcome of this trial is overall comfort, measured with the General Comfort Scale total score before and after the procedure. This was corrected on October 30, 2026. Pain was assessed at all planned time points and is reported as a secondary outcome.

Study Design Study type: Interventional (clinical trial) Design: Single-center, prospective, two-arm, parallel-group randomized controlled trial Allocation: Randomized (1:1) Masking: None (open label). Because of the nature of the intervention, participants, the nurse researcher delivering the intervention and the practitioners could not be blinded. Data were coded before analysis, and the analyses were performed by a researcher who was not involved in data collection.

Setting: Family planning outpatient clinic of a women's and children's hospital, Gaziantep, Türkiye Study period: October 2024 to March 2025 Sample Size The sample size was calculated with G*Power 3.1.9.4 for a repeated-measures analysis of variance (two groups, two measurements), with a significance level of 5% (alpha = 0.05), a power of 95% and an effect size of f = 0.40. The minimum required sample was 64 women (32 per group). To allow for possible data loss, the target sample was set at 70 women (35 per group).

Participant Flow Eighty-nine women who agreed to participate were assessed for eligibility. Nineteen did not meet the eligibility criteria (visual impairment, n = 5; psychiatric disorder, n = 2; severe dizziness, n = 4; analgesic use before the procedure, n = 8). The remaining 70 women were randomized (experimental group = 35, control group = 35). No participant withdrew or was lost to follow-up, and all 70 women were included in the analysis.

Randomization and Groups Participants were individually randomized in a 1:1 ratio to the experimental or control group by lottery. Seventy identical slips of white paper, 35 labeled "experimental group" and 35 labeled "control group," were placed in a bag. After giving written informed consent and completing the baseline assessments, and before IUD insertion, each eligible woman drew one slip from the bag; drawn slips were not returned.

Given the nature of the intervention, information exchange between participants (contamination) could have influenced the results. To minimize this risk, women waited in a separate waiting area before the procedure, were called into the procedure room individually and, after the procedure, left the clinic through a separate exit that did not lead back to the waiting area.

Baseline characteristics of the groups were compared statistically, and baseline-adjusted analyses were used to account for any imbalances.

Note: An earlier version of this record described day-based allocation. This description has been corrected to reflect the individual lottery-based randomization that was actually implemented.

Intervention Experimental group (virtual reality group): In addition to routine care, women received a virtual reality-assisted nursing intervention based on Kolcaba's Comfort Theory. The nurse researcher prepared each woman for the procedure and used virtual reality to increase her comfort and reduce her anxiety. Women watched a nature-themed 360-degree video (water, forest and sky scenes) with soothing music, lasting approximately 6 minutes, through a virtual reality headset. The video was started 2 minutes before insertion and continued until it ended after insertion. The intervention was designed as a non-pharmacological nursing intervention to divert attention away from the procedure and to reduce pain and anxiety.

Control group (routine care): Women received routine care according to the clinic's standard practice, without virtual reality or any other study intervention.

All participants received a copper IUD inserted by the practitioners on duty. Materials

  1. Virtual reality headset: Samsung Gear VR (SM-R321NZWATUR), used with a smartphone
  2. Virtual reality video: "Virtual Nature 360° - 5K Nature Meditation for Daydream, Oculus, Gear VR," featuring nature scenes accompanied by calming music Data Collection Data were collected by trained researchers through face-to-face interviews in three phases; each session took approximately 15 to 20 minutes.

Before the procedure: Descriptive Characteristics Questionnaire; General Comfort Scale; visual analogue scales for anticipated pain, tension, fear/anxiety, irritability and contentment; blood pressure, pulse rate and respiratory rate. Allocation slips were drawn after these assessments.

During the procedure: pain (visual analogue scale) and pulse rate immediately after speculum insertion, tenaculum application and IUD placement.

After the procedure (5 minutes): blood pressure, pulse rate and respiratory rate; visual analogue scales for pain, tension, fear/anxiety, irritability and contentment; General Comfort Scale. Procedure duration (minutes), practitioner satisfaction and adverse events (such as dizziness, nausea and headset discomfort) were also recorded.

Vital signs were measured in both groups by the same researcher with the same device.

Data Collection Instruments Descriptive Characteristics Questionnaire: Prepared by the researchers on the basis of the literature; it covers age, education, employment, income, health insurance, obstetric history, current contraceptive use and its duration, previous IUD use, the person who decided on IUD use and negative information about IUDs received from the social environment.

General Comfort Scale: Developed by Kolcaba and adapted into Turkish, the scale consists of 48 four-point Likert-type items in three subscales (relief, ease and transcendence). Negative items are reverse-scored. Total scores range from 48 to 192, and higher scores indicate greater comfort. Cronbach's alpha was 0.85 for the Turkish version.

Visual analogue scales: Tension, fear/anxiety, irritability and contentment were each rated on a 100-mm scale from 0 (none) to 100 (most intense). Pain was rated on a 100-mm scale from 0 (no pain) to 100 (worst imaginable pain). Before the procedure, women rated on the same scale the pain they expected to feel during insertion (anticipated pain). The practitioner rated satisfaction with the procedure on a 100-mm scale from 0 (not at all satisfied) to 100 (completely satisfied).

Ethics Ethical approval was obtained from the SANKO University Clinical Research Ethics Committee (Decision No. 2023/24; December 21, 2023), together with institutional permission. The study followed the Declaration of Helsinki. Participants were informed about the aims and procedures of the study, and written informed consent was obtained from all participants.

Statistical Analysis Data were analyzed with IBM SPSS Statistics 25.0. Normality was assessed by skewness and kurtosis, homogeneity of variances by Levene's test and homogeneity of covariance matrices by Box's M test. Baseline characteristics were compared with the chi-square, Fisher's exact or Fisher-Freeman-Halton exact test and the independent-samples t-test, and standardized mean differences were calculated.

Intervention effects were estimated with analysis of covariance (ANCOVA), using the post-procedure score as the dependent variable, group as the fixed factor and the baseline score as the covariate (anticipated pain for pain after the procedure). ANCOVA assumptions (linearity, homogeneity of regression slopes, normality and homogeneity of residuals, influential observations) were checked. Sensitivity analyses included additional covariates for imbalanced baseline characteristics, heteroscedasticity-consistent (HC3) standard errors and a mixed-design repeated-measures ANOVA (group x time).

Variables not suitable for parametric testing (irritability, pain, procedure duration and practitioner satisfaction) were compared with the Mann-Whitney U test, and within-group change in pain with the Wilcoxon signed-rank test. Intraprocedural pain was compared with the Mann-Whitney U test and intraprocedural pulse rate with ANCOVA adjusted for baseline pulse rate. All tests were two-sided, and p < 0.05 was considered significant.

研究の種類

介入

入学 (実際)

70

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

18年歳以上 (大人、高齢者)

健康ボランティアの受け入れ

はい

受講資格のある性別

女性

説明

Inclusion Criteria:

Aged 18 years or older Sexually active Decided to undergo intrauterine device insertion after routine contraceptive counseling Suitable candidate for intrauterine device insertion on gynecological examination No communication difficulties

Exclusion Criteria:

Visual or hearing impairment Diagnosed psychiatric disorder Severe facial injury History of epilepsy or severe dizziness Analgesic use before the procedure Any contraindication to intrauterine device insertion

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:支持療法
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:なし(オープンラベル)

武器と介入

参加者グループ / アーム
介入・治療
実験的:Virtual reality group

Intervention Type: Behavioral Intervention Name: Virtual reality-supported nursing intervention Other Intervention Names: VR-supported nursing intervention Assign to Arm: Experimental: Virtual reality group Description:Routine care plus the virtual reality-supported nursing intervention during IUD insertion.

In addition to routine care, women received a virtual reality-supported nursing intervention based on Kolcaba's Comfort Theory. The nurse prepared each woman for the procedure and used virtual reality to increase comfort and reduce anxiety. Women watched a nature-themed 360-degree video with relaxing music (approximately 6 minutes) through a head-mounted display (Samsung Gear VR), started 2 minutes before insertion and continued until the video ended.

Intervention Name: Virtual Reality Intervention

Description:

Participants in the experimental group received a virtual reality-assisted nursing intervention during intrauterine device insertion. A virtual reality headset was used to present a 3D immersive video including relaxing natural scenes and calming background music. The intervention was applied continuously throughout the procedure to distract attention from the procedure and reduce pain and anxiety.

Intervention Name: Routine Care

Description:

Participants in the control group received routine care during intrauterine device insertion without the use of virtual reality or any additional distraction method.

介入なし:Control Group

Arm Title Control group Arm Type No Intervention Arm Description Routine care according to the clinic's standard practice, without virtual reality or any other study intervention.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
General Comfort Scale total score
時間枠:Before IUD insertion (baseline) and 5 minutes after the procedure

Overall comfort was measured with the Turkish version of Kolcaba's General Comfort Scale, which consists of 48 items rated on a four-point Likert scale. Total scores range from 48 to 192, with higher scores indicating greater comfort.

Before IUD insertion (baseline) and 5 minutes after the procedure

二次結果の測定

結果測定
メジャーの説明
時間枠
General Comfort Scale subscale scores (relief, ease and transcendence)
時間枠:Before IUD insertion (baseline) and 5 minutes after the procedure

Scores of the relief, ease and transcendence subscales of the General Comfort Scale; higher scores indicate greater comfort.

Before IUD insertion (baseline) and 5 minutes after the procedure
Emotional state scores (tension, fear/anxiety, irritability and contentment)
時間枠:Before IUD insertion (baseline) and 5 minutes after the procedure

Each emotional state was rated on a single-item 100-mm visual analog scale ranging from 0 (none) to 100 (most intense).

Before IUD insertion (baseline) and 5 minutes after the procedure
Pain intensity (visual analog scale)
時間枠:Before the procedure (anticipated pain); immediately after speculum insertion, tenaculum application and IUD placement; and 5 minutes after the procedure

Pain was rated on a 100-mm visual analog scale from 0 (no pain) to 100 (worst imaginable pain). Before the procedure, women rated the pain they expected to feel during insertion (anticipated pain).

Before the procedure (anticipated pain); immediately after speculum insertion, tenaculum application and IUD placement; and 5 minutes after the procedure
Pulse rate (beats per minute
時間枠:Before the procedure; immediately after speculum insertion, tenaculum application and IUD placement; and 5 minutes after the procedure

Pulse rate was measured by the same researcher with the same device in both groups.

Before the procedure; immediately after speculum insertion, tenaculum application and IUD placement; and 5 minutes after the procedure
Respiratory rate (breaths per minute)
時間枠:Before the procedure and 5 minutes after the procedure

Respiratory rate was counted by the same researcher in both groups.

Before the procedure and 5 minutes after the procedure
Systolic and diastolic blood pressure (mmHg)
時間枠:Before the procedure and 5 minutes after the procedure

Blood pressure was measured by the same researcher with the same device in both groups.

Before the procedure and 5 minutes after the procedure
Duration of IUD insertion (minutes
時間枠:During the procedure

Time from the start to the end of the insertion procedure, recorded by the researcher in whole minutes.

During the procedure
Practitioner satisfaction with the procedure
時間枠:Immediately after the procedure

The practitioner performing the insertion rated overall satisfaction with the procedure on a single-item 100-mm visual analog scale from 0 (not at all satisfied) to 100 (completely satisfied).

Immediately after the procedure

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

捜査官

  • スタディチェア:Emine BAŞ, PhD、Sanko University
  • スタディチェア:Zeynep GÜNGÖRMÜŞ, Prof、Gaziantep Islam Science and Technology University
  • 主任研究者:Yasemin ATEŞEYAN, PhD、MERSİN UNIVERSITY
  • スタディチェア:Esra VERİM, PhD、GAZİANTEP UNIVERSITY

出版物と役立つリンク

研究に関する情報を入力する責任者は、自発的にこれらの出版物を提供します。これらは、研究に関連するあらゆるものに関するものである可能性があります。

一般刊行物

  • Aydın, A., Araz, A., Asan, A. 2011. Görsel Analog Ölçeği ve Duygu Kafesi: Kültürümüze Uyarlama Çalışması, Türk Psikoloji Yazıları,14 (27), 1-13.
  • Kolcaba, K. (2003). Comfort Theory and Practice A vision for holistik health care and research, Springer Publishing Company. New York
  • Kuğuoğlu, S., & Karabacak, Ü. (2008). Genel Konfor Ölçeğinin Türkçe 'ye uyarlanması. İstanbul Üniversitesi Florence Nightingale Hemşirelik Yüksekokulu Dergisi, 61(16), 16-23.

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2024年10月25日

一次修了 (実際)

2025年3月30日

研究の完了 (実際)

2026年3月10日

試験登録日

最初に提出

2026年4月17日

QC基準を満たした最初の提出物

2026年5月5日

最初の投稿 (実際)

2026年5月12日

学習記録の更新

投稿された最後の更新 (実際)

2026年11月3日

QC基準を満たした最後の更新が送信されました

2026年10月30日

最終確認日

2026年10月1日

詳しくは

本研究に関する用語

その他の研究ID番号

  • SANKO UNIVERSITY
  • YASEMİN ATEŞEYAN (レジストリ識別子:VR-IUD)

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

IPD プランの説明

Data are available from the corresponding author upon reasonable request because of privacy and ethical restrictions.

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。